Click here for slides on this topic


Warfarin

An oral antiplatelet agent of the glycoproetin (Gp) IIb/IIIa inhibitor class.
The following content matched the glossary term: Warfarin

Sitagliptin: a novel agent for the management of type 2 diabetes mellitus

Top

Pham DQ, Nogid A, Plakogiannis R. Sitagliptin: a novel agent for the management of type 2 diabetes mellitus. Am J Health Syst Pharm. 2008;65(6):521-31. The pharmacologic, pharmacokinetic, safety, clinical efficacy, and role of sitagliptin in the management of type 2 diabetes mellitus are reviewed.

Measures for Reducing the Incidence of Events in Patients With CVD Are Available but Too Often Are Not Applied(2)

Top

Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update. A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581-1583. In 1995, the American Heart Association published, and the American College of Cardiology endorsed, the original consensus statement on the secondary prevention of heart attack and death in patients with established atherosclerotic cardiovascular disease (CVD).



Slide Library Results

Search Results for: Warfarin Slides Found: 0